Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medicare Part D Mandatory Rebates Advised By Budget Experts At Super Committee Hearing

This article was originally published in The Pink Sheet Daily

Executive Summary

Hearing witnesses also urge the committee to endorse an overhaul of Medicare that allows private plans to compete with the fee-for-service program through a federal exchange.

You may also be interested in...

Part D Rebates Would Contribute More Than Half Of Medicare Savings In White House Plan

Plan seeks to cut Medicare costs by a total of $248 billion over 10 years, with mandatory rebates in Part D contributing $135 billion.

"Medicare Exchange" Proposal From Healthcare Leadership Council Could Deter Threat Of Part B Drug Payment Reductions

Healthcare Leadership Council sends "super committee" recommendations, including Medicare reforms, that could save $410 billion in health care costs.

Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind

Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts